top of page
Search

Comments


Logo_PNG.png

In the LARISSA project, six consortium partners work with CEPI to develop and validate a novel vaccine against Rift Valley Fever. It is the first vaccine that potentially provides full protection with a single dose and has an optimal safety profile. 

Subscribe to Our Newsletter

Thanks for submitting!

CONTACT >

E: info@bunyavax.com

© 2019 by BunyaVax BV.

bottom of page